These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10218402)

  • 21. Human obesity and insulin resistance: lessons from experiments of nature.
    O'Rahilly S
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):33-6. PubMed ID: 17212584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin resistance: from benign to type 2 diabetes mellitus.
    Goldstein BJ
    Rev Cardiovasc Med; 2003; 4 Suppl 6():S3-10. PubMed ID: 14668698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.
    Invitti C; Gilardini L; Pontiggia B; Morabito F; Mazzilli G; Viberti G
    Nutr Metab Cardiovasc Dis; 2006 May; 16(4):256-62. PubMed ID: 16679217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of type 2 diabetes in individuals with central obesity in a rural Japanese population: the Tanno and Sobetssu study: Response to Ohnishi et al.
    Oda E
    Diabetes Care; 2006 Aug; 29(8):1988-9. PubMed ID: 16873826
    [No Abstract]   [Full Text] [Related]  

  • 25. [Type 2 diabetes: why screen, how to prevent?].
    Manus JM
    Rev Infirm; 2005 Nov; (115):18-9. PubMed ID: 16375241
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiovascular risk in the spectrum of type 2 diabetes mellitus.
    Ahmed I; Goldstein BJ
    Mt Sinai J Med; 2006 Sep; 73(5):759-68. PubMed ID: 17008936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity.
    McLaughlin T; Abbasi F; Lamendola C; Reaven G
    Arch Intern Med; 2007 Apr; 167(7):642-8. PubMed ID: 17420421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical implications of insulin resistance.
    Peters AL
    Am J Manag Care; 2000 Aug; 6(13 Suppl):S668-74; discussion S675-81. PubMed ID: 11183420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 2 diabetes mellitus in childhood--a global perspective.
    Laron Z
    J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():459-69. PubMed ID: 12017218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms linking obesity to insulin resistance and type 2 diabetes.
    Kahn SE; Hull RL; Utzschneider KM
    Nature; 2006 Dec; 444(7121):840-6. PubMed ID: 17167471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of and risk factors for cataract among diabetes clinic attenders.
    Janghorbani MB; Jones RB; Allison SP
    Ophthalmic Epidemiol; 2000 Mar; 7(1):13-25. PubMed ID: 10652168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [From obesity to type 2 diabetes, epidemiological landmarks].
    Sauvanet JP
    Soins; 2004 Apr; (684 Pt 2):3. PubMed ID: 15151083
    [No Abstract]   [Full Text] [Related]  

  • 33. Impaired glucose tolerance: obesity and inactivity as modifiable risk factors.
    Taylor K
    Adv Nurse Pract; 2001 Dec; 9(12):59-61. PubMed ID: 12400355
    [No Abstract]   [Full Text] [Related]  

  • 34. Prescreening tools for diabetes and obesity-associated dyslipidaemia: comparing BMI, waist and waist hip ratio. The D.E.S.I.R. Study.
    Balkau B; Sapinho D; Petrella A; Mhamdi L; Cailleau M; Arondel D; Charles MA;
    Eur J Clin Nutr; 2006 Mar; 60(3):295-304. PubMed ID: 16278693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Genetic predisposition for multiple metabolic syndrome. Part 1. Diabetes mellitus type 2--incidence and prevalence].
    Sobra J
    Cas Lek Cesk; 1999 Jan; 138(1):6-11. PubMed ID: 10953428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Obesity in children and adolescents and diabetes].
    Nazim J; Starzyk J
    Przegl Lek; 2009; 66(1-2):96-9. PubMed ID: 19485265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity and other risk factors in children.
    Falkner B; Michel S
    Ethn Dis; 1999; 9(2):284-9. PubMed ID: 10421092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dietary nutrition and non-insulin-dependent diabetes mellitus].
    Wang Y; Cassano P; Chen J
    Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Jul; 33(4):244-7. PubMed ID: 15384238
    [No Abstract]   [Full Text] [Related]  

  • 39. [Nonpharmacological diabetes therapy].
    Martin S
    Med Klin (Munich); 2006 Dec; 101(12):973-89; quiz 990-1. PubMed ID: 17171321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
    Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.